BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10510088)

  • 21. Tolerance in vivo and in vitro.
    Tomonari K
    Immunol Rev; 1990 Aug; 116():139-57. PubMed ID: 2227992
    [No Abstract]   [Full Text] [Related]  

  • 22. The stimulation of low-affinity, nontolerized clones by heteroclitic antigen analogues causes the breaking of tolerance established to an immunodominant T cell epitope.
    Wang R; Wang-Zhu Y; Gabaglia CR; Kimachi K; Grey HM
    J Exp Med; 1999 Oct; 190(7):983-94. PubMed ID: 10510088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T-lymphocyte response to cytochrome c. I. Demonstration of a T-cell heteroclitic proliferative response and identification of a topographic antigenic determinant on pigeon cytochrome c whose immune recognition requires two complementing major histocompatibility complex-linked immune response genes.
    Solinger AM; Ultee ME; Margoliash E; Schwartz RH
    J Exp Med; 1979 Oct; 150(4):830-48. PubMed ID: 92520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of antigen-presenting cell major histocompatibility complex gene products to the specificity of antigen-induced T cell activation.
    Heber-Katz E; Schwartz RH; Matis LA; Hannum C; Fairwell T; Appella E; Hansburg D
    J Exp Med; 1982 Apr; 155(4):1086-99. PubMed ID: 6174670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functionally distinct agretopic and epitopic sites. Analysis of the dominant T cell determinant of moth and pigeon cytochromes c with the use of synthetic peptide antigens.
    Fox BS; Chen C; Fraga E; French CA; Singh B; Schwartz RH
    J Immunol; 1987 Sep; 139(5):1578-88. PubMed ID: 2442249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. H-2-restricted cytolytic T lymphocytes specific for HLA display T cell receptors of limited diversity.
    Casanova JL; Cerottini JC; Matthes M; Necker A; Gournier H; Barra C; Widmann C; MacDonald HR; Lemonnier F; Malissen B; Maryanski JL
    J Exp Med; 1992 Aug; 176(2):439-47. PubMed ID: 1380061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Termination of peripheral tolerance to a T cell epitope by heteroclitic antigen analogues.
    Zügel U; Wang R; Shih G; Sette A; Alexander J; Grey HM
    J Immunol; 1998 Aug; 161(4):1705-9. PubMed ID: 9712034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endogenous myelin basic protein inactivates the high avidity T cell repertoire.
    Targoni OS; Lehmann PV
    J Exp Med; 1998 Jun; 187(12):2055-63. PubMed ID: 9625765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct evidence that functionally impaired CD4+ T cells persist in vivo following induction of peripheral tolerance.
    Pape KA; Merica R; Mondino A; Khoruts A; Jenkins MK
    J Immunol; 1998 May; 160(10):4719-29. PubMed ID: 9590217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection.
    Zhao ZS; Granucci F; Yeh L; Schaffer PA; Cantor H
    Science; 1998 Feb; 279(5355):1344-7. PubMed ID: 9478893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD4 augments the response of a T cell to agonist but not to antagonist ligands.
    Hampl J; Chien YH; Davis MM
    Immunity; 1997 Sep; 7(3):379-85. PubMed ID: 9324358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone.
    Hemmer B; Fleckenstein BT; Vergelli M; Jung G; McFarland H; Martin R; Wiesmüller KH
    J Exp Med; 1997 May; 185(9):1651-9. PubMed ID: 9151902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular mimicry and T cell-mediated autoimmune disease.
    Barnaba V; Sinigaglia F
    J Exp Med; 1997 May; 185(9):1529-31. PubMed ID: 9151889
    [No Abstract]   [Full Text] [Related]  

  • 34. Tolerance to p53 by A2.1-restricted cytotoxic T lymphocytes.
    Theobald M; Biggs J; Hernández J; Lustgarten J; Labadie C; Sherman LA
    J Exp Med; 1997 Mar; 185(5):833-41. PubMed ID: 9120389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conditions that induce tolerance in mature CD4+ T cells.
    Lanoue A; Bona C; von Boehmer H; Sarukhan A
    J Exp Med; 1997 Feb; 185(3):405-14. PubMed ID: 9053441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential T cell signaling induced by antagonist peptide-MHC complexes and the associated phenotypic responses.
    La Face DM; Couture C; Anderson K; Shih G; Alexander J; Sette A; Mustelin T; Altman A; Grey HM
    J Immunol; 1997 Mar; 158(5):2057-64. PubMed ID: 9036949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positive selection of T cells induced by viral delivery of neopeptides to the thymus.
    Nakano N; Rooke R; Benoist C; Mathis D
    Science; 1997 Jan; 275(5300):678-83. PubMed ID: 9005856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1(27-35).
    Loftus DJ; Castelli C; Clay TM; Squarcina P; Marincola FM; Nishimura MI; Parmiani G; Appella E; Rivoltini L
    J Exp Med; 1996 Aug; 184(2):647-57. PubMed ID: 8760818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct measurement of anergy of antigen-specific T cells following oral tolerance induction.
    Van Houten N; Blake SF
    J Immunol; 1996 Aug; 157(4):1337-41. PubMed ID: 8759712
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.